CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth

Suppressed Expression of Cbl-b by NF-κB Mediates Icotinib Resistance in EGFR-mutant Non-Small-Cell Lung Cancer

(2018) Tieqiong Zhang et al.   CELL BIOLOGY INTERNATIONAL

Differential Characterization of Temozolomide-Resistant Human Glioma Cells

(2018) Sheng-Wei Lai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inhibition of the PI3K/Akt signaling pathway reverses sorafenib‑derived chemo‑resistance in hepatocellular carcinoma

(2018) Hao Zhang et al.   Oncology Letters

The Role of Adenosine Receptors in Psychostimulant Addiction

(2018) Inmaculada Ballesteros-Yáñez et al.   Frontiers in Pharmacology

Targeting adenosine in cancer immunotherapy: a review of recent progress

(2017) Theresa L Whiteside   Expert Review of Anticancer Therapy

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

(2017) Mohammad H. Kazemi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives

(2017) Amirhossein Bahreyni et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling

(2017) Daniel Uribe et al.   MOLECULAR ASPECTS OF MEDICINE

Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis

(2017) Davide Tiziano Di Carlo et al.   NEUROSURGICAL REVIEW

The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression

(2017) Geoffrey Burnstock et al.   Purinergic Signalling

Purinergic Signalling: Therapeutic Developments

(2017) Geoffrey Burnstock   Frontiers in Pharmacology

AKT/GSK3β Signaling in Glioblastoma

(2016) Ewelina Majewska et al.   NEUROCHEMICAL RESEARCH

Extracellular purines, purinergic receptors and tumor growth

(2016) F Di Virgilio et al.   ONCOGENE

Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients

(2016) Lin Lin et al.   TUMOR BIOLOGY

Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells

(2016) Angelo Torres et al.   Oncotarget

Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells

(2015) Elizandra Braganhol et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas

(2015) Alfeu Zanotto-Filho et al.   CANCER LETTERS

Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme

(2015) Giuseppe Musumeci et al.   CELL AND TISSUE RESEARCH

CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis

(2015) Patrycja Koszałka et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro

(2015) Isabele C. Iser et al.   MOLECULAR NEUROBIOLOGY

Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy

(2015) Kirk E. Cahill et al.   NEURO-ONCOLOGY

Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer

(2015) YUAN YUAN et al.   Oncology Letters

Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation

(2015) Maria Teresa Gentile et al.   PLoS One

Adenosine Receptors Differentially Regulate the Expression of Regulators of G-Protein Signalling (RGS) 2, 3 and 4 in Astrocyte-Like Cells

(2015) Till Nicolas Eusemann et al.   PLoS One

The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor

(2014) Tian-zhu Liu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

CD73 Participates in Cellular Multiresistance Program and Protects against TRAIL-Induced Apoptosis

(2014) A. Mikhailov et al.   JOURNAL OF IMMUNOLOGY

Nucleotide signalling during inflammation

(2014) Marco Idzko et al.   NATURE

Role of adenosine in status epilepticus: A potential new target?

(2013) Detlev Boison   EPILEPSIA

Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas

(2013) Shuo Xu et al.   NEURO-ONCOLOGY

CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth

(2012) Bertrand Allard et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells

(2012) Claudia Quezada et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The Adenosine A3 Receptor Agonist Cl-IB-MECA Induces Cell Death Through Ca2+/ROS-Dependent Down Regulation of ERK and Akt in A172 Human Glioma Cells

(2012) Thae Hyun Kim et al.   NEUROCHEMICAL RESEARCH

Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion

(2011) Angélica Regina Cappellari et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Selective NTPDase2 expression modulatesin vivorat glioma growth

(2009) Elizandra Braganhol et al.   CANCER SCIENCE

Prostatic acid phosphatase, a neglected ectonucleotidase

(2009) Herbert Zimmermann   Purinergic Signalling

A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model

(2008) Elizandra Braganhol et al.   CELL AND TISSUE RESEARCH

The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation

(2008) Luci Bavaresco et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY